Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: A longitudinal observational study

被引:9
作者
Choi, Young Min [1 ,2 ]
Hwang, Kyu Ri [3 ]
Oh, So Hee [4 ]
Lee, Dayong [5 ]
Chae, Soo Jin [6 ]
Yoon, Sang Ho [7 ]
Kim, Jin Ju [1 ,2 ,8 ]
机构
[1] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Med Res Ctr, Inst Reprod Med & Populat, Seoul, South Korea
[3] SMG SNU Boramae Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[4] SMG SNU Boramae Med Ctr, Dept Biostat, Seoul, South Korea
[5] Kyungpook Natl Univ, Dept Obstet & Gynecol, Sch Med, Daegu, South Korea
[6] IORA Fertil Clin, Dept Obstet & Gynecol, Suwon, South Korea
[7] Dongguk Univ, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea
[8] Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Obstet & Gynecol, Seoul 06236, South Korea
关键词
Diabetes; Glycaemic status; Polycystic ovary syndrome; Prediabetes; IMPAIRED GLUCOSE-TOLERANCE; RISK-FACTOR; HEMOGLOBIN; MELLITUS; COHORT;
D O I
10.1111/cen.14416
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate changes in glycaemic status in women with polycystic ovary syndrome (PCOS). Design Longitudinal observational study. Patients Women with PCOS who underwent baseline and follow-up screening tests for diabetes (n = 262). Four patients with type 2 diabetes (T2DM) at baseline and 6 patients who were taking drugs at the final follow-up were excluded. Measurements Changes in glycaemic classification based on fasting glucose, haemoglobin A1c and oral glucose tolerance test. Results The median length of follow-up was 2.9 years. The mean age and body mass index in the normoglycaemia group (n = 202) were 23.0 years and 21.6 kg/m(2), while it was 23.6 years and 22.9 kg/m(2) in the prediabetes group (n = 50). In the normoglycaemia group, 38 (18.8%) and 2 (1.0%) developed prediabetes and T2DM, respectively. In the prediabetes group, 22 (44.0%) remained in the same category, 6 (12.0%) developed T2DM, while 22 (44.0%) achieved normoglycaemia. The incidence rate of T2DM was 9.3 per 1,000 person-years, which was significantly higher than that of the female population of similar age, and the incidence was higher in women with fasting glucose >= 5.6 mmol/L at baseline than in women with 5.6 mmol/L. Conclusions About 20% of normoglycaemic women had developed prediabetes or T2DM after a median time of 2.9 years. Meanwhile, nearly half of prediabetes women achieved normoglycaemia. Higher baseline fasting glucose levels were associated with an increased incidence of T2DM. Our results are the first to evaluate glycaemic status changes using all three parameters in patients with PCOS.
引用
收藏
页码:837 / 844
页数:8
相关论文
共 28 条
  • [1] Diagnosis and follow-up of type 2 diabetes in women with PCOS: a role for OGTT?
    Andersen, Marianne
    Glintborg, Dorte
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 179 (03) : D1 - D14
  • [2] [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS3, DOI 10.2337/dc10-S003
  • [3] Risk of T2DM and impaired fasting glucose among PCOS subjects: Results of an 8-year follow-up
    Boureaux M.Y.
    Talbott E.O.
    Kip K.E.
    Brooks M.M.
    Witchel S.F.
    [J]. Current Diabetes Reports, 2006, 6 (1) : 77 - 83
  • [4] Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study
    Celik, Cem
    Tasdemir, Nicel
    Abali, Remzi
    Bastu, Ercan
    Yilmaz, Murat
    [J]. FERTILITY AND STERILITY, 2014, 101 (04) : 1123 - U568
  • [5] Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women
    Chae, Soo Jin
    Kim, Jin Ju
    Choi, Young Min
    Hwang, Kyu Ri
    Jee, Byung Chul
    Ku, Seung Yup
    Suh, Chang Suk
    Kim, Seok Hyun
    Kim, Jung Gu
    Moon, Shin Yong
    [J]. HUMAN REPRODUCTION, 2008, 23 (08) : 1924 - 1931
  • [6] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [7] Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study
    Ding, Tao
    Hardiman, Paul J.
    Petersen, Irene
    Baio, Gianluca
    [J]. HUMAN REPRODUCTION, 2018, 33 (07) : 1299 - 1306
  • [8] The metabolic syndrome
    Eckel, RH
    Grundy, SM
    Zimmet, PZ
    [J]. LANCET, 2005, 365 (9468) : 1415 - 1428
  • [9] Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome
    Ehrmann, DA
    Barnes, RB
    Rosenfield, RL
    Cavaghan, MK
    Imperial, J
    [J]. DIABETES CARE, 1999, 22 (01) : 141 - 146
  • [10] ElSayed NA, 2023, DIABETES CARE, V46, pS19, DOI [10.2337/dc23-S002, 10.2337/dc19-S002, 10.2337/dc18-S002, 10.2337/dc09-S062, 10.2337/dc12-S064]